The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma
Status:
Active, not recruiting
Trial end date:
2021-09-28
Target enrollment:
Participant gender:
Summary
This proposal is for a pilot study comparing volumes of 18F-DOPA-PET avidity with contrast
enhancement and T2 FLAIR on MRI. Investigators then plan to compare patterns of failure with
target volumes, pre-treatment MRI changes and pre-treatment 18F-DOPA-PET.